The Royal Swedish Academy of Sciences announced on Wednesday that Henri B. Kagan and Kenso Soai have been awarded the 2026 Nobel Prize in Chemistry for discoveries that illuminate one of chemistry's most enduring puzzles: how biological molecules came to favor one mirror-image form over another.
The two scientists were honored for their work on non-linear effects and autocatalysis in asymmetric organic synthesis, according to the announcement made in Stockholm. Their findings, the Academy said, address a question that has confounded researchers for more than a hundred years.
At the heart of the mystery is the phenomenon known as homochirality. Many molecules exist in two forms that are mirror images of each other, much like a left hand and a right hand. On Earth, living organisms display a striking preference for one handedness over the other—amino acids, for instance, are almost exclusively left-handed, while the sugars in DNA are right-handed. How this uniformity arose from what should have been a random chemical mixture has long been an open question.
Heiner Linke, chair of the Nobel Committee for Chemistry, explained the significance of the pair's contribution in a statement released by the Academy. According to Linke, Kagan and Soai have provided a solution to the puzzle of how homochirality can emerge spontaneously. He described the chemical reactions they developed as "spectacular."
Kagan was born in France and is affiliated with Université Paris-Sud in Orsay. Soai, who is 95 years old and was born in Japan, is associated with the Tokyo University of Science. The Academy cited both researchers for discoveries that have proven crucial for chemists engaged in designing reactions used in the manufacture of pharmaceuticals.
The significance for medicine is considerable. Many drugs are chiral—meaning their two mirror-image forms can behave very differently inside the body. In some notorious cases, one form of a drug provides the intended therapeutic benefit while its mirror image produces harmful side effects. The ability to selectively produce just one desired form has therefore become a central challenge in pharmaceutical chemistry, and the work of Kagan and Soai has offered chemists important tools for meeting it.
Kagan's research focused on non-linear effects in asymmetric synthesis, a field that examines how the enantiomeric purity of a catalyst or starting material can influence the purity of the final product in unexpected ways. His findings showed that the relationship between input and output chirality is not always a simple, straight-line correspondence, a revelation with broad implications for designing efficient chemical processes.
Soai's contribution centers on the phenomenon of autocatalysis, in which a reaction produces a substance that catalyzes its own formation. The reaction named after him, widely known as the "Soai reaction," demonstrated that a chemical system can amplify a tiny initial imbalance in chirality, causing one mirror-image form to come to dominate the mixture. This self-reinforcing process offered a plausible chemical mechanism by which homochirality could have emerged spontaneously on the early Earth.
The announcement continues this year's Nobel Prize season, which opened on Monday with the medicine prize. That award went to three scientists whose work led to the development of a tool with significant biological applications.
Last year's chemistry prize honored three researchers for creating new molecular structures capable of trapping large quantities of gas within them. Those framework-like materials raised the prospect of extracting greenhouse gases from the atmosphere or harvesting moisture from arid desert air, demonstrating the practical ambitions that often accompany Nobel-recognized chemical research.
The 2026 award places Kagan and Soai in a long tradition of Nobel laureates whose work has bridged fundamental questions about nature with tangible applications. Their discoveries not only shed light on how the molecular asymmetry of life might have originated but also gave chemists practical strategies for controlling the handedness of the molecules they create.
For the pharmaceutical industry, those strategies have become increasingly valuable. Regulatory agencies in many countries now require drugmakers to thoroughly characterize and control the chirality of their products, making efficient asymmetric synthesis methods essential rather than optional. The insights pioneered by Kagan and Soai have helped make such control achievable on a commercial scale.
The Academy's decision also highlights the ongoing interplay between curiosity-driven research and real-world utility. The question of why life prefers one molecular handedness began as a purely theoretical puzzle about the origins of biology, yet the efforts to answer it yielded chemical techniques that now serve medicine and manufacturing.
In announcing the prize, the Academy underscored the pair's role in resolving a mystery that had resisted explanation for generations. The spontaneous emergence of homochirality, once considered an inexplicable feature of the living world, now has a demonstrated chemical basis thanks to their experimental work.
The Nobel Prize in Chemistry is one of the most prestigious scientific honors in the world, awarded annually by the Royal Swedish Academy of Sciences. The prize recognizes discoveries that have conferred the greatest benefit on humankind, and this year's selection acknowledges both the intellectual depth of Kagan and Soai's research and its lasting practical influence.
Further Nobel announcements are expected in the coming days as the annual prize week continues.
(0)